Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.-Reference-Cited by-同舟云学术

Transparency and Reproducibility of Observational Cohort Studies Using Large Healthcare Databases.

Published:2016-02-17 Issue:3 Volume:99 Page:325-332
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Wang SV¹,Verpillat P²,Rassen JA³,Patrick A³,Garry EM⁴,Bartels DB²⁵

Affiliation:

1. Division of Pharmacoepidemiology and Pharmacoeconomics; Harvard Medical/Brigham & Women's Hospital; Boston Massachusetts USA

2. Corporate Department Global Epidemiology; Boehringer Ingelheim; Ingelheim Germany

3. Aetion, Inc.; New York New York USA

4. Department of Epidemiology; University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA

5. Hannover Medical School; Hannover Germany

Funder

Agency for Healthcare Research and Quality

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.329/fullpdf

Reference43 articles.

1. Drug development: raise standards for preclinical cancer research.;Begley;Nature,2012

2. The cancer test.;Kaiser;Science,2015

3. Scientific standards. Promoting an open research culture.;Nosek;Science,2015

4. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) http://www.encepp.eu/ 2014

5. PCORI Methodology Committee Hickam , D. Totten , A. Berg , A. Rader , K. Goodman , S. Newhouse , R The PCORI Methodology Report 2013 http://www.pcori.org/assets/2013/11/PCORI-Methodology-Report.pdf

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective Monitoring of New Drugs in Older Adults with and without Frailty: Near-Real-Time Assessment of Effectiveness and Safety of Oral Anticoagulants in Medicare Data;Drugs & Aging;2024-09-11

2. Transparency in the secondary use of health data: Assessing the status quo of guidance and best practices;2024-08-11

3. Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc);Vaccines;2024-06-11

4. Antidepressant discontinuation patterns and characteristics across sociodemographic groups in the United States;Journal of Affective Disorders;2024-06

5. Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review;Pharmacoepidemiology and Drug Safety;2024-05